--- title: News, Events & Resources | CBS Admin (3) description: News, events, case studies and more - stay in touch with all the exciting progress at Crystal Bio Solutions. (3) --- ![Logo\_CBS-横版-原色(RGB)](https://www.crystalbiosolutions.com/hs-fs/hubfs/Logo_CBS-%E6%A8%AA%E7%89%88-%E5%8E%9F%E8%89%B2(RGB)-2.png?width=330&height=150&name=Logo_CBS-%E6%A8%AA%E7%89%88-%E5%8E%9F%E8%89%B2(RGB)-2.png) - [Bioanalysis & Biomarkers](https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers) - [Characterization & CMC Analytical](https://www.crystalbiosolutions.com/characterization-cmc-analytical) - [Clinical Pharmacology](https://www.crystalbiosolutions.com/services/clinical-pharmacology) - [Regulatory Affairs](https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt) - [Clinical Support](https://www.crystalbiosolutions.com/clinical-research-services) - [Resources](https://www.crystalbiosolutions.com/news-and-events) - [About Us](https://www.crystalbiosolutions.com/about-us) - [Contact Us](https://www.crystalbiosolutions.com/contact-us) ![AdobeStock\_712273576](https://www.crystalbiosolutions.com/hs-fs/hubfs/Licensed-Assets/AdobeStock_712273576.jpeg?width=960&height=640&name=AdobeStock_712273576.jpeg) # News, events, and resources All White Paper Blog Case Study news and events Dec 15, 2025 ![Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality](https://www.crystalbiosolutions.com/hs-fs/hubfs/ADC%20structure.png?width=320&height=240&name=ADC%20structure.png) Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality Overview of ADC components and related CQAs, highlighting how antibody, linker, and payload heterogeneity affect potency, stability and ... Nov 21, 2025 ![Strategies for Antibody-Drug Conjugates Bioanalysis](https://www.crystalbiosolutions.com/hs-fs/hubfs/Thumbnail-Crystal-Bio-Solutions.png?width=320&height=240&name=Thumbnail-Crystal-Bio-Solutions.png) Strategies for Antibody-Drug Conjugates Bioanalysis Antibody-drug conjugates (ADCs) bioanalysis requires robust methods to track antibodies, payloads, and drug-to-antibody ratio changes in ... Oct 9, 2025 ![Improving NAb Assay Sensitivity and Drug Tolerance by Optimizing MRD](https://www.crystalbiosolutions.com/hs-fs/hubfs/CS%20-%20Blog%20%20Thumbnail-2.png?width=320&height=240&name=CS%20-%20Blog%20%20Thumbnail-2.png) Improving NAb Assay Sensitivity and Drug Tolerance by Optimizing MRD Adjusting Minimal Required Dilution (MRD) from 1:4 to 1:2 in a competitive ligand binding assay improved NAb assay sensitivity 4-fold and ... Sep 18, 2025 ![Representative Pooled Matrix Selection is Critical in ADA Assays](https://www.crystalbiosolutions.com/hs-fs/hubfs/6.png?width=320&height=240&name=6.png) Representative Pooled Matrix Selection is Critical in ADA Assays Our scientists developed a strategy to reduce false positives and improve the reliability of ADA assays Sep 18, 2025 ![A Generic LC-MS/MS Solution for ADC PK Bioanalysis](https://www.crystalbiosolutions.com/hs-fs/hubfs/LC-MS-MS-ADC-PK-Bioanalysis.png?width=320&height=240&name=LC-MS-MS-ADC-PK-Bioanalysis.png) A Generic LC-MS/MS Solution for ADC PK Bioanalysis Our experts developed a highly sensitive and specific workflow to quantify total antibodies, conjugated payload, and free payload in ... Sep 18, 2025 ![An immunogenicity analysis strategy to reduce the interference of soluble target proteins](https://www.crystalbiosolutions.com/hs-fs/hubfs/9.png?width=320&height=240&name=9.png) An immunogenicity analysis strategy to reduce the interference of soluble target proteins Our experts established a bioanalytical strategy to eliminate false positive signals caused by soluble drug targets in ADA assays, ... Sep 18, 2025 ![Receptor occupancy of antibody drug measured by flow cytometry](https://www.crystalbiosolutions.com/hs-fs/hubfs/7.png?width=320&height=240&name=7.png) Receptor occupancy of antibody drug measured by flow cytometry Our experts developed a PD-1 receptor occupancy (RO) assay to monitor drug–target interactions and support pharmacodynamic evaluation in ... Sep 17, 2025 ![Dr. Lorin K. Roskos Appointed Chief Scientific Officer and Head of Quantitative Clinical Pharmacology](https://www.crystalbiosolutions.com/hs-fs/hubfs/Dr-Loris-Roskos-CSO-Crystal-Bio-Solutions.png?width=320&height=240&name=Dr-Loris-Roskos-CSO-Crystal-Bio-Solutions.png) Dr. Lorin K. Roskos Appointed Chief Scientific Officer and Head of Quantitative Clinical Pharmacology Dr. Lorin K. Roskos joins CBS as CSO & Head of Quantitative Clinical Pharmacology (QCP), bringing 30+ years of R&D expertise to ... Sep 16, 2025 ![A LC-MS/MS Method for Oligonucleotide PK Bioanalysis](https://www.crystalbiosolutions.com/hs-fs/hubfs/LC-MSMS-Oligonucleotide-PK-Bioanalysis.png?width=320&height=240&name=LC-MSMS-Oligonucleotide-PK-Bioanalysis.png) A LC-MS/MS Method for Oligonucleotide PK Bioanalysis In this case study our experts developed an LC-MS/MS method for oligonucleotide pharmacokinetic (PK) analysis in a Phase 1 clinical studies. Sep 16, 2025 ![Immunophenotyping to identify peripheral lymphocyte subsets](https://www.crystalbiosolutions.com/hs-fs/hubfs/4-1.png?width=320&height=240&name=4-1.png) Immunophenotyping to identify peripheral lymphocyte subsets Discover how our experts developed FACS-based immunophenotyping method to monitor T and NK cell populations in solid tumor treatment ... ![Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality](https://www.crystalbiosolutions.com/hs-fs/hubfs/ADC%20structure.png?width=320&height=240&name=ADC%20structure.png) Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality Overview of ADC components and related CQAs, highlighting how antibody, linker, and payload heterogeneity affect potency, stability and ... ![Strategies for Antibody-Drug Conjugates Bioanalysis](https://www.crystalbiosolutions.com/hs-fs/hubfs/Thumbnail-Crystal-Bio-Solutions.png?width=320&height=240&name=Thumbnail-Crystal-Bio-Solutions.png) Strategies for Antibody-Drug Conjugates Bioanalysis Antibody-drug conjugates (ADCs) bioanalysis requires robust methods to track antibodies, payloads, and drug-to-antibody ratio changes in ... ![Improving NAb Assay Sensitivity and Drug Tolerance by Optimizing MRD](https://www.crystalbiosolutions.com/hs-fs/hubfs/CS%20-%20Blog%20%20Thumbnail-2.png?width=320&height=240&name=CS%20-%20Blog%20%20Thumbnail-2.png) Improving NAb Assay Sensitivity and Drug Tolerance by Optimizing MRD Adjusting Minimal Required Dilution (MRD) from 1:4 to 1:2 in a competitive ligand binding assay improved NAb assay sensitivity 4-fold and ... ![Representative Pooled Matrix Selection is Critical in ADA Assays](https://www.crystalbiosolutions.com/hs-fs/hubfs/6.png?width=320&height=240&name=6.png) Representative Pooled Matrix Selection is Critical in ADA Assays Our scientists developed a strategy to reduce false positives and improve the reliability of ADA assays ![A Generic LC-MS/MS Solution for ADC PK Bioanalysis](https://www.crystalbiosolutions.com/hs-fs/hubfs/LC-MS-MS-ADC-PK-Bioanalysis.png?width=320&height=240&name=LC-MS-MS-ADC-PK-Bioanalysis.png) A Generic LC-MS/MS Solution for ADC PK Bioanalysis Our experts developed a highly sensitive and specific workflow to quantify total antibodies, conjugated payload, and free payload in ... ![An immunogenicity analysis strategy to reduce the interference of soluble target proteins](https://www.crystalbiosolutions.com/hs-fs/hubfs/9.png?width=320&height=240&name=9.png) An immunogenicity analysis strategy to reduce the interference of soluble target proteins Our experts established a bioanalytical strategy to eliminate false positive signals caused by soluble drug targets in ADA assays, ... ![Receptor occupancy of antibody drug measured by flow cytometry](https://www.crystalbiosolutions.com/hs-fs/hubfs/7.png?width=320&height=240&name=7.png) Receptor occupancy of antibody drug measured by flow cytometry Our experts developed a PD-1 receptor occupancy (RO) assay to monitor drug–target interactions and support pharmacodynamic evaluation in ... ![A LC-MS/MS Method for Oligonucleotide PK Bioanalysis](https://www.crystalbiosolutions.com/hs-fs/hubfs/LC-MSMS-Oligonucleotide-PK-Bioanalysis.png?width=320&height=240&name=LC-MSMS-Oligonucleotide-PK-Bioanalysis.png) A LC-MS/MS Method for Oligonucleotide PK Bioanalysis In this case study our experts developed an LC-MS/MS method for oligonucleotide pharmacokinetic (PK) analysis in a Phase 1 clinical studies. ![Immunophenotyping to identify peripheral lymphocyte subsets](https://www.crystalbiosolutions.com/hs-fs/hubfs/4-1.png?width=320&height=240&name=4-1.png) Immunophenotyping to identify peripheral lymphocyte subsets Discover how our experts developed FACS-based immunophenotyping method to monitor T and NK cell populations in solid tumor treatment ... ![Dr. Lorin K. Roskos Appointed Chief Scientific Officer and Head of Quantitative Clinical Pharmacology](https://www.crystalbiosolutions.com/hs-fs/hubfs/Dr-Loris-Roskos-CSO-Crystal-Bio-Solutions.png?width=320&height=240&name=Dr-Loris-Roskos-CSO-Crystal-Bio-Solutions.png) Dr. Lorin K. Roskos Appointed Chief Scientific Officer and Head of Quantitative Clinical Pharmacology Dr. Lorin K. Roskos joins CBS as CSO & Head of Quantitative Clinical Pharmacology (QCP), bringing 30+ years of R&D expertise to ... ### Subscribe to **our newsletter!** ![Logo\_CBS-竖版-反白](https://www.crystalbiosolutions.com/hubfs/Logo_CBS-%E7%AB%96%E7%89%88-%E5%8F%8D%E7%99%BD.png) - [Our Services](https://www.crystalbiosolutions.com) - [Bioanalysis and Biomarker](https://www.crystalbiosolutions.com/services/bioanalysis-and-biomarkers) - [CMC Analytical](https://www.crystalbiosolutions.com/characterization-cmc-analytical) - [Clinical Pharmacology](https://www.crystalbiosolutions.com/services/clinical-pharmacology) - [Regulatory Affairs](https://www.crystalbiosolutions.com/services/regulatory-affairs-biologics-adc-cgt) - [Clinical Support](https://www.crystalbiosolutions.com/clinical-research-services) - [Information](https://www.crystalbiosolutions.com/news-and-events) - [Resources](https://www.crystalbiosolutions.com/news-and-events) - [News & Events](https://www.crystalbiosolutions.com/news-and-events) - [Careers](https://www.crystalbiosolutions.com/careers-at-crystal-bio-solutions) - [About us](https://www.crystalbiosolutions.com/about-us) - [Contact](https://www.crystalbiosolutions.com/contact-us) - [Email \>](mailto:cbs_bd@crystalpharmatech.com) - [Contact Form](https://www.crystalbiosolutions.com/contact-us) - [Our Locations](https://www.crystalbiosolutions.com/locations) - [Crystal Group \>](https://www.crystalpharmatech.com/) - [Crystal Pharmatech](https://www.crystalpharmatech.com/) - [Crystal NAX](https://www.crystalnax.com/) - [Privacy Policy](https://www.crystalbiosolutions.com/policies/privacy-policy) - [Terms of Service](https://www.crystalbiosolutions.com/policies/terms-of-service) Copyright © 2026 Crystal Bio Solutions, All rights reserved